Seek, Find, and Treat: Best Practices for Managing Patients with Transthyretin Amyloid Polyneuropathy (ATTR-PN)
Oct 29, 2025
Managing Worsening Heart Failure with Reduced Ejection Fraction: Strategies for Successful Outcomes
Aug 04, 2024
Improving Pump Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Challenges and Opportunities
Mar 23, 2022
Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes
Nov 04, 2021
From Glycemic Control to Cardiorenal Protection: Improving Outcomes With SGLT2 Inhibitors
May 15, 2021
Reducing LDL-C and Cardiovascular Risk with Nonstatin Therapy: From Evidence to Practice
Jul 02, 2019
March 14, 2015
Jeffrey Anderson, MD, Van de Werf,MD and Marc Sabatine MD, discuss timing/location, dosing, duration of oral antiplatelet therapies, clinical trials, and guidelines.
No Credit Available